Eikon Therapeutics, a company headed by the former Merck executive who steered the cancer drug Keytruda to FDA approval, has raised $350.7 million to support a pipeline that includes a lead drug ...
Eikon Therapeutics emerged with the promise of Nobel Prize-winning molecule tracking technology. But now, CEO Roger Perlmutter, M.D., Ph.D., and co. are using their more than $600 million war chest ...
HAYWARD, Calif.--(BUSINESS WIRE)--Eikon Therapeutics, Inc., which advances breakthrough therapeutics through the purposeful integration of engineering and science, announced today that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback